Stock Earnings

Question 1

Corcept Therapeutics Inc 的关键财务报表是什么？

Accepted Answer

根据最新的财务报表（Form-10K），Corcept Therapeutics Inc 的总资产为 $840，净profit为 $141

Question 2

CORT 的关键财务比率是什么？

Accepted Answer

Corcept Therapeutics Inc 的流动比率是 5.25，净利 margin 为 20.88，每股销售为 $5.94。

Question 3

Corcept Therapeutics Inc 的收入按细分市场或地理位置如何划分？

Accepted Answer

Corcept Therapeutics Inc largest revenue segment is Pharmaceutical, at a revenue of 675,040,000 in the most earnings release.For geography, United States is the primary market for Corcept Therapeutics Inc, at a revenue of 675,040,000.

Question 4

Corcept Therapeutics Inc 是否盈利？

Accepted Answer

yes，根据最新的财务报表，Corcept Therapeutics Inc 的净profit为 $141

Question 5

Corcept Therapeutics Inc 有负债吗？

Accepted Answer

yes，Corcept Therapeutics Inc 的负债为 160

Question 6

Corcept Therapeutics Inc 的流通股有多少？

Accepted Answer

Corcept Therapeutics Inc 的总流通股为 105.11

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	716	675	482	401	366	353
Revenue Growth (YoY)	26%	40%	20%	10%	4%	15%
Cost of Revenue	11	10	6	5	5	5
Gross Profit	704	664	475	396	360	348
Selling, General & Admin	351	280	184	152	122	105
Research & Development	250	246	184	131	113	114
Operating Expenses	602	527	368	283	236	220
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	126	161	124	116	125	131
Income Tax Expense	-7	20	18	14	12	25
Net Income	133	141	106	101	112	106
Net Income Growth	6%	33%	5%	-10%	6%	13%
Shares Outstanding (Diluted)	120.48	113.48	111.74	116	126	124.2
Shares Change (YoY)	8%	2%	-4%	-8%	1%	1%
EPS (Diluted)	1.1	1.24	0.94	0.87	0.89	0.85
EPS Growth	-3%	31%	9%	-2%	5%	10%
Free Cash Flow	180	195	126	119	167	150
Free Cash Flow Per Share	1.49	1.71	1.12	1.02	1.32	1.2
Gross Margin	98.32%	98.37%	98.54%	98.75%	98.36%	98.58%
Operating Margin	14.1%	20.14%	22.19%	27.93%	33.87%	36.26%
Profit Margin	18.57%	20.88%	21.99%	25.18%	30.6%	30.02%
Free Cash Flow Margin	25.13%	28.88%	26.14%	29.67%	45.62%	42.49%
EBITDA	101	136	108	112	125	128
EBITDA Margin	14.1%	20.14%	22.4%	27.93%	34.15%	36.26%
D&A For EBITDA	0	0	1	0	1	0
EBIT	101	136	107	112	124	128
EBIT Margin	14.1%	20.14%	22.19%	27.93%	33.87%	36.26%
Effective Tax Rate	-5.55%	12.42%	14.51%	12.06%	9.6%	19.08%

Corcept Therapeutics Inc (CORT) Price

CORT Stock Price Chart

CORT Income

Follow-Up Questions